Keyphrases
Fibrosis
100%
PNPLA3
100%
Transmembrane 6 Superfamily Member 2 (TM6SF2)
100%
HSD17B13
100%
Metabolic-associated Fatty Liver Disease (MAFLD)
100%
Significant Fibrosis
83%
Fibrosis-4 (FIB-4)
66%
Liver Disease
50%
Genetic Risk Score
50%
Odds Ratio
16%
Single nucleotide Polymorphism
16%
Non-associated
16%
Danish Population
16%
Risk Variant
16%
Body Mass Index
16%
Risk Allele
16%
Malignant Disease
16%
Diagnostic Accuracy
16%
Disease Risk
16%
Adult Individuals
16%
Genetic Testing
16%
At-risk
16%
Liver Biopsy
16%
Alcoholic Liver Disease
16%
Mild Fibrosis
16%
Rs738409
16%
Fibroscan
16%
Rs58542926
16%
Elevated ALT
16%
Medicine and Dentistry
Population
100%
Liver Disease
100%
Fibrosis
100%
PNPLA3
100%
Genetic Risk
30%
Disease
20%
Allele
10%
Odds Ratio
10%
Body Mass Index
10%
Diagnostic Accuracy
10%
Single Nucleotide Polymorphism
10%
Genetic Screening
10%
Liver Biopsy
10%
FibroScan
10%
Alcohol-Related Liver Disease
10%
Biochemistry, Genetics and Molecular Biology
Population
100%
PNPLA3
100%
Genetic Risk
60%
Single-Nucleotide Polymorphism
20%
Allele
20%
Body Mass
20%
Genetic Screening
20%
Immunology and Microbiology
Population
100%
Genetic Risk
100%
Single Nucleotide Polymorphism
33%
Body Mass
33%
Allele
33%
Genetic Screening
33%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Disease
100%
Fibrosis
100%
Genetic Risk
30%
Disease
20%
Ethanol
10%